Short answer · Medically reviewed summary · Last updated: 2026-04-07
Aplastic anemia is most commonly referred to by its primary name, though it is occasionally historicaly termed "hypoplastic anemia" or "panmyelophthisis." While these terms describe the same underlying failure of the bone marrow to produce blood cells, "aplastic anemia" remains the standardized clinical term used by medical professionals and international health organizations globally. What are the historical and alternative names for Aplastic Anemia? The medical literature has evolved significantly since the condition was first described in the late 19th century. Historically, Aplastic Anemia was sometimes referred to as "Ehrlich’s anemia," named after Paul Ehrlich, who provided the first clinical description in 1888.
Aplastic Anemia synonyms
Other names for Aplastic Anemia: synonyms, acronyms and related terms used by doctors and patients.
Aplastic anemia is most commonly referred to by its primary name, though it is occasionally historicaly termed "hypoplastic anemia" or "panmyelophthisis." While these terms describe the same underlying failure of the bone marrow to produce blood cells, "aplastic anemia" remains the standardized clinical term used by medical professionals and international health organizations globally.
What are the historical and alternative names for Aplastic Anemia?
The medical literature has evolved significantly since the condition was first described in the late 19th century. Historically, Aplastic Anemia was sometimes referred to as "Ehrlich’s anemia," named after Paul Ehrlich, who provided the first clinical description in 1888. In older medical texts, you may encounter the term "panmyelophthisis," which refers to the wasting away of all bone marrow elements. Another synonym occasionally found in literature is "hypoplastic anemia," though this term is now more commonly reserved for conditions where bone marrow function is reduced but not completely absent, distinguishing it from the more severe state of Aplastic Anemia.
How is Aplastic Anemia classified in medical systems?
Standardization is vital for clinical research and patient care. In official classification systems, the condition is consistently recognized as Aplastic Anemia. The following identifiers are used by major medical databases to ensure consistency across the global healthcare community:
- Orphanet: ORPHA:769 (Aplastic anemia)
- OMIM: #609135 (Aplastic anemia)
- ICD-10: D61.9 (Aplastic anemia, unspecified)
- ICD-11: 3A70 (Aplastic anemia)
Why does Aplastic Anemia have multiple names?
The presence of multiple names for Aplastic Anemia stems from the historical progression of hematology. Before modern bone marrow biopsy techniques and molecular diagnostics were available, physicians relied on observational pathology, leading to descriptive names like "panmyelophthisis." As our understanding of the immune-mediated destruction of hematopoietic stem cells improved, the medical community consolidated these terms. Today, using the term Aplastic Anemia ensures clear communication between hematologists, oncologists, and patients, preventing confusion with other blood disorders like myelodysplastic syndromes or Fanconi anemia.
Why is "Aplastic Anemia" the preferred term?
Medical professionals prefer Aplastic Anemia because it accurately reflects the pathophysiology of the disease: "a-" (without) and "plastic" (growth/formation). Unlike other forms of anemia that may be caused by nutritional deficiencies or blood loss, this condition involves a profound failure of the bone marrow to produce red blood cells, white blood cells, and platelets. The 357 members of the DiseaseMaps.org community living with this diagnosis use this standardized terminology to share experiences and access targeted treatment protocols like rATG, hATG, and bone marrow transplantation.
Next steps
- Consult with a board-certified hematologist to confirm your specific diagnosis and subtype.
- Verify your medical records use the standardized ICD-10 or ICD-11 codes for Aplastic Anemia to ensure correct insurance billing and clinical tracking.
- Join the community at DiseaseMaps.org to connect with 357 other individuals who have navigated the challenges of this rare condition.
- Review the latest clinical trial information via the NIH GARD portal to stay informed about emerging therapies.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): https://rarediseases.info.nih.gov/diseases/5775/aplastic-anemia
- Orphanet: https://www.orpha.net/en/disease/detail/769
- OMIM (Online Mendelian Inheritance in Man): https://omim.org/entry/609135
- Aplastic Anemia & MDS International Foundation: https://www.aamds.org
